J. Mel Sorensen
2023
In 2023, J. Mel Sorensen earned a total compensation of $1.3M as President and Chief Executive Officer at Galera Therapeutics, a 8% decrease compared to previous year.
Compensation breakdown
| Option Awards | $617,628 |
|---|---|
| Salary | $616,505 |
| Other | $16,132 |
| Total | $1,250,265 |
Sorensen received $617.6K in option awards, accounting for 49% of the total pay in 2023.
Sorensen also received $616.5K in salary and $16.1K in other compensation.
Rankings
In 2023, J. Mel Sorensen's compensation ranked 974th out of 3,006 executives tracked by ExecPay. In other words, Sorensen earned more than 67.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 974 out of 3,006 | 68th |
Division Manufacturing | 576 out of 1,650 | 65th |
Major group Chemicals And Allied Products | 394 out of 918 | 57th |
Industry group Drugs | 383 out of 881 | 57th |
Industry Pharmaceutical Preparations | 260 out of 637 | 59th |
Source: SEC filing on January 24, 2025.
Sorensen's colleagues
We found three more compensation records of executives who worked with J. Mel Sorensen at Galera Therapeutics in 2023.
News
Galera Therapeutics CEO J Sorensen's 2023 pay slips 8% to $1.3M
January 24, 2025
Galera Therapeutics CEO J Sorensen's 2022 pay falls 46% to $1.4M
April 27, 2023
Galera Therapeutics CEO J Sorensen's 2021 pay slips 14% to $2.5M
April 28, 2022
Galera Therapeutics CEO J Sorensen's 2019 pay jumps 373% to $2.5M
April 27, 2020